中空纤维系统模型在结核病中的应用：欧洲药品管理局的经验。
Hollow Fiber System Model for Tuberculosis: The European Medicines Agency Experience.
机构信息
Human Medicines Evaluation Division-Anti-infectives and Vaccines.
Human Medicines Research and Development Support Division-Scientific Advice, European Medicines Agency, London, United Kingdom.
出版信息
Clin Infect Dis. 2015 Aug 15;61 Suppl 1:S1-4. doi: 10.1093/cid/civ484.
PMID:26224766
Abstract
The in vitro hollow fiber system model has been qualified by the European Medicines Agency as a methodology for use in support of selection and development of antituberculosis regimens. More data are expected to be generated in the future to further characterize its value.
摘要
体外中空纤维系统模型已被欧洲药品管理局确认为一种支持抗结核方案选择和开发的方法学。预计未来将产生更多数据，以进一步确定其价值。
Zotero 插件